GWEN SHATTUCK: Open Payments
NPI 1497204432 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,632 in 109 payments from 46 companies in 2025. Trend: 2023 $2,758 · 2024 $2,518 · 2025 $2,632
Food & beverage: $2,508Education: $100Speaker / faculty: $24
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 11 | $253 |
| Novartis Pharmaceuticals Corporation | 7 | $178 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $138 |
| Ipsen Biopharmaceuticals, Inc | 2 | $129 |
| AstraZeneca Pharmaceuticals LP | 5 | $115 |
| Acrotech Biopharma Inc. | 4 | $110 |
| SOBI, INC | 5 | $108 |
| Regeneron Healthcare Solutions, Inc. | 4 | $96 |
| Incyte Corporation | 4 | $96 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
Products named: KEYTRUDA, BELEODAQ, LIBTAYO, Vonjo, KISQALI, VENCLEXTA, BRUKINSA, SCEMBLIX.
Industry payments across SC — which companies pay providers there.
